Guidance

Influenza vaccine (IIV and LAIV) patient group direction (PGD)

PGD template for administering inactivated influenza vaccine or live attenuated influenza vaccine, in line with the national seasonal flu vaccination programme.

• From: UK Health Security Agency
• Published: 18 June 2026

Applies to England

Documents

Influenza vaccine (IIV and LAIV) patient group direction (PGD)

MS Word Document, 794 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.

If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

This patient group direction (PGD) template supports the administration of either inactivated influenza vaccine (IIV) or live attenuated influenza vaccine (LAIV) as part of the national seasonal influenza vaccination programme.

The Influenza PGD version 1.0 is valid from 1 September 2026 to 31 March 2027.

This PGD template should be used with reference to current national guidance, the Green Book and Summary of product characteristics for the vaccine.

Published 18 June 2026